drugset / Trial / NCT00987441

Epidural Labor Analgesia and Infant Neurobehavior

NCT00987441

Completed 1200 enrolled Nanjing Medical University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Infant neurobehavior alteration is predictor of later intelligence development. Many factors would influence or are associated with infant neurobehavior, of which exist or appear during perinatal period. Neuraxial, especially epidural, analgesia to date is the most effective method in relieving labor pain. Although previous studies showed that opioid used in epidural analgesia for labor pain can affect newborn neurobehavior negatively in a dose-escalation associated manner, whether epidural analgesia itself would produce unpredictable effect on newborn neurobehavior is still unknown. Hereby the investigators designed this trial to investigate the hypothesis that epidural analgesia for labor pain control itself would not produce negative effect on infant neurobehavior.

Timeline

Start
2009-09
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 0.0625 % Other
Comparator Ropivacaine Other / unclassified 0.125 % Other
Comparator Ropivacaine Other / unclassified 0.1875 % Other
Comparator Ropivacaine Other / unclassified 0.25 % Other
Comparator Sufentanil Other / unclassified 0.3 ug/ml Other
Comparator Sufentanil Other / unclassified 0.4 ug/ml Other
Comparator Sufentanil Other / unclassified 0.5 ug/ml Other

Indications

No indication recorded.